Research / AI / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-22-024099 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
23.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-58.58% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
24.62% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
71.82% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-112.10% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
85.56% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
86.71% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Oct 31, 2021 0/6 normalized Level 3 Jan 31, 2022 0/7 normalized Level 3 Apr 30, 2022 0/7 normalized Level 3 Jul 31, 2022 0/7 normalized Level 3 Oct 31, 2022 0/7 normalized Level 3 Jan 31, 2023 4/7 normalized Level 3 Apr 30, 2023 6/7 normalized Level 3 Jul 31, 2023 6/7 normalized Level 3 Oct 31, 2023 6/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.50%
Current 23.79%
Delta 22.29% Cash Generation Decreased
Previous -34.21%
Current -58.58%
Delta -24.37% Growth Decreased
Previous 37.96%
Current 24.62%
Delta -13.34% Margin Decreased
Previous 74.79%
Current 71.82%
Delta -2.98% Profitability Decreased
Previous -77.59%
Current -112.10%
Delta -34.51% R And D Intensity Increased
Previous 59.56%
Current 85.56%
Delta 26.00% Sbc Intensity Increased
Previous 44.88%
Current 86.71%
Delta 41.83% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.